AtriCure, Inc. (ATRC) Posts Q1 Loss of 10c/Share
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.47 +2.33%
EPS Growth %: -300.0%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -300.0%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q1 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $19.4 million versus the consensus estimate of $18.62 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Astrana Health (ASTH) Mentioned as short at Glass House
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
